Overdiagnosis and overtreatment of prostate cancer):104655. 5. HAS. Rapport d'évaluation technologique Destruction par ultrasons focalisés de haute intensité par voie rectale d'un adénocarcinome localisé de la prostate première prescription du psa chez l'homme asymptomatique, Dec 6. Assurance Maladie, Collège de Médecine Générale, 2010. ,
Guidelines on Prostate-Cancer, 2016. ,
Recommandations en onco-urologie 2013 du CCAFU : Cancer de la prostate, Progr??s en Urologie, vol.23, p.2013 ,
DOI : 10.1016/S1166-7087(13)70048-4
Technological changes in the management of prostate cancer result in increased healthcare costs--a retrospective study in a defined Swedish population):22631. 12. HAS. Guide Méthodologique Choix méthodologiques pour l'évaluation économique à la HAS, Roberts M et al. Conceptualizing a Model: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2. Med Decis Making, pp.678-89, 2003. ,
Patient perspective on watchful waiting/active surveillance for localized prostate cancer):76370. 15. HAS. Guide ALD Cancer de la Prostate Prostate Cancer : diagnosis and treatment A taxonomy of model structures for economic evaluation of health technologies, J Am Board Fam Med JABFM. déc NICE. Clinical Guideline Health Econ. déc, vol.2515, issue.612, p.1295310, 2006. ,
DOI : 10.3122/jabfm.2012.06.120128
URL : http://www.jabfm.org/content/25/6/763.full.pdf
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer, New England Journal of Medicine, vol.375, issue.15, p.141524, 2016. ,
DOI : 10.1056/NEJMoa1606220
Metastasis After Radical Prostatectomy or External Beam Radiotherapy for Patients With Clinically Localized Prostate Cancer: A Comparison of Clinical Cohorts Adjusted for Case Mix, Journal of Clinical Oncology, vol.28, issue.9, p.150813, 2010. ,
DOI : 10.1200/JCO.2009.22.2265
Meta-analysis in clinical trials, Controlled Clinical Trials, vol.7, issue.3, p.17788, 1986. ,
DOI : 10.1016/0197-2456(86)90046-2
165-1-1 du code de la sécurité sociale de la destruction par ultrasons focalisés de haute intensité par voie rectale d'un adénocarcinome localisé de la prostate | Legifrance Cost study of the clinical management of prostate cancer in France: results on the basis of population-based data, Eur J Health Econ HEPAC Health Econ Prev Care. août, vol.12, issue.4, p.36371, 2011. ,
Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer., Health Technology Assessment, vol.16, issue.41, p.1313, 2012. ,
DOI : 10.3310/hta16410
The Half-Cycle Correction Revisited, Medical Decision Making, vol.29, issue.4, p.96170, 2013. ,
DOI : 10.1177/0272989X09340585
Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly: a feasibility study with 10 years follow-up, International braz j urol, vol.16, issue.101, pp.213-219, 2011. ,
DOI : 10.1111/j.1442-2042.2009.02389.x
A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer, Prostate Cancer and Prostatic Disease, vol.18, issue.1, p.7983, 2016. ,
DOI : 10.1155/2014/186782
Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 Patients, European Urology, vol.71, issue.2, p.26773, 2017. ,
DOI : 10.1016/j.eururo.2016.09.039
Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer, BJU International, vol.29, issue.11, p.16727, 2012. ,
DOI : 10.1097/01.pas.0000173646.99337.b1
Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study, European Urology, vol.63, issue.4, p.597603, 2013. ,
DOI : 10.1016/j.eururo.2012.11.005
A multi-institutional evaluation of active surveillance for low risk prostate cancer, J Urol. janv, vol.189, issue.1, pp.1925-1950, 2013. ,
A single centre experience of active surveillance as management strategy for low-risk prostate cancer in Ireland, Irish Journal of Medical Science (1971 -), vol.111, issue.7, p.37782, 2014. ,
DOI : 10.1111/j.1464-410X.2012.11641.x
Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Göteborg randomised population-based prostate cancer screening trial, Eur Urol. janv, vol.63, issue.1, p.1017, 2013. ,
Active surveillance in low-risk prostate cancer. Patient acceptance and results, Actas Urol??gicas Espa??olas (English Edition), vol.37, issue.9, p.5337, 2013. ,
DOI : 10.1016/j.acuroe.2013.02.005
Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer, Journal of Clinical Oncology, vol.33, issue.3, p.2727, 2015. ,
DOI : 10.1200/JCO.2014.55.1192
Five-year nationwide followup study of active surveillance for prostate cancer, Eur Urol. févr, vol.67, issue.2, p.2338, 2015. ,
Acceptance and durability of surveillance as a management choice in men with screen-detected, low-risk prostate cancer: improved outcomes with stringent enrollment criteria, Urology. avr, vol.77, issue.4, p.9804, 2011. ,
Active surveillance for low-risk prostate cancer: Need for intervention and survival at 10 years, Urologic Oncology: Seminars and Original Investigations, vol.33, issue.9, pp.383-392, 2015. ,
DOI : 10.1016/j.urolonc.2015.04.015
Careful Selection and Close Monitoring of Low-Risk Prostate Cancer Patients on Active Surveillance Minimizes the Need for Treatment, European Urology, vol.58, issue.6, p.8315, 2010. ,
DOI : 10.1016/j.eururo.2010.08.027
Medium-term oncological outcomes for extended vs saturation biopsy and transrectal vs transperineal biopsy in active surveillance for prostate cancer, BJU International, vol.105, issue.Suppl. 2, p.88491, 2015. ,
DOI : 10.1111/j.1464-410X.2009.08938.x
Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer, Journal of Clinical Oncology, vol.33, issue.30, p.337985, 2015. ,
DOI : 10.1200/JCO.2015.62.5764
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863946/pdf
Active surveillance program for prostate cancer: an update of the Johns Hopkins experience Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial, J Clin Oncol Off J Am Soc Clin Oncol. 1 juin J Natl Cancer Inst, vol.29100, issue.4216, p.218590114454, 2008. ,
Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multiinstitutional collaboration Tobacco use and outcome in radical prostatectomy patients, Eur Urol. août Cancer Med. avr, vol.606, issue.24, p.85764, 2011. ,
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial, The Lancet Oncology, vol.15, issue.4, p.46473, 2014. ,
DOI : 10.1016/S1470-2045(14)70040-3
Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy, European Urology, vol.70, issue.4, p.58896, 2016. ,
DOI : 10.1016/j.eururo.2016.01.008
The Natural History of Men Treated With Deferred Androgen Deprivation Therapy in Whom Metastatic Prostate Cancer Developed Following Radical Prostatectomy, The Journal of Urology, vol.179, issue.1, pp.156-161, 2008. ,
DOI : 10.1016/j.juro.2007.08.133
Oncologic Outcome and Patterns of Recurrence after Salvage Radical Prostatectomy, European Urology, vol.55, issue.2, p.40410, 2009. ,
DOI : 10.1016/j.eururo.2008.07.007
Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-na??ve patients, BJU International, vol.176, issue.3, p.174854, 2011. ,
DOI : 10.1016/j.juro.2006.06.017
Pathological, Oncologic and Functional Outcomes of Radical Prostatectomy Following Active Surveillance, The Journal of Urology, vol.190, issue.1, p.915, 2013. ,
DOI : 10.1016/j.juro.2013.01.019
Radical Prostatectomy versus External Beam Radiotherapy for cT1-4N0M0 Prostate Cancer: Comparison of Patient Outcomes Including Mortality Radical prostatectomy versus observation for localized prostate cancer, PloS One. N Engl J Med, vol.10367, issue.103, pp.141123-5320313, 2012. ,
External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer. The Prostate. 1 mai Populationbased 10-year event-free survival after radical prostatectomy for patients with prostate cancer in British Columbia, Can Urol Assoc J, vol.679, issue.6, pp.65360-5540913, 1112. ,
Metastasis After Radical Prostatectomy or External Beam Radiotherapy for Patients With Clinically Localized Prostate Cancer: A Comparison of Clinical Cohorts Adjusted for Case Mix, Journal of Clinical Oncology, vol.28, issue.9, p.150813, 2010. ,
DOI : 10.1200/JCO.2009.22.2265
Brachytherapy versus prostatectomy in localized prostate cancer: Results of a French multicenter prospective medico-economic study, International Journal of Radiation Oncology*Biology*Physics, vol.67, issue.3, p.81222, 2007. ,
DOI : 10.1016/j.ijrobp.2006.10.011
Utilities for prostate cancer health states in men aged 60 and older, Med Care. avr, vol.43, issue.4, p.34755, 2005. ,
A Method Based on the Remaining Value of Perfect Information for the Sample Size Calculation in Randomized Trial-Based Cost-Effectiveness Analyses, Value in Health, vol.18, issue.7, p.71920, 2015. ,
DOI : 10.1016/j.jval.2015.09.2725
diagnostic"[All Fields] AND "imaging"[All Fields]) OR "diagnostic imaging"[All Fields] OR "ultrasound"[All Fields] OR "ultrasonography"[MeSH Terms] OR "ultrasonography"[All Fields] OR "ultrasound"[All Fields] OR "ultrasonics"[MeSH Terms] OR "ultrasonics, OR (ablatherm[All Fields] OR ablathermie ,
Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 ,
53 = 281,2 personnes-année Extraction des incidences : -6 prostatectomies radicales (nPR) -3 radiothérapie (nRT) -2 décès ,